Print
|
Close
Randall E. Pierce MD
Northwest Georgia Oncology Centers
www.ngoc.com
Education and Training
Specialty and Certification
Medical Oncology / Board Certified
Clinical Trial Cancer Types
Breast Cancer, Cancer-Related Syndrome, Esophogeal Cancer, Leukemia, Myelodysplastic Syndromes (MDS), Solid Tumor, Stomach/ Gastric Cancer
Affiliations
Tanner Health System
Active Clinical Trial Sites in Georgia
Northwest Georgia Oncology Centers - Carrollton
157 Clinic Avenue
Suite 101
Carrollton, GA 30117
770-333-2220 (p)
678-581-7180 (f)
www.ngoc.com
driving directions
Clinical Trials
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Cancer Type: Breast Cancer
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Cancer Type: Breast Cancer
Connect® Myeloid Disease Registry
Cancer Type: Cancer-Related Syndrome
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Cancer Type: Esophogeal Cancer
Connect® Myeloid Disease Registry
Cancer Type: Leukemia
Connect® Myeloid Disease Registry
Cancer Type: Myelodysplastic Syndromes (MDS)
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Cancer Type: Solid Tumor
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Cancer Type: Stomach/ Gastric Cancer
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Cancer Type: Unknown Primary
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Cancer Type: Unknown Primary
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Cancer Type: Unknown Primary
Northwest Georgia Oncology Centers - Villa Rica
705 Dallas Highway
Suite 204
Villa Rica, GA 30180
770-771-5935 (p)
770-771-5931 (f)
www.ngoc.com
driving directions
Clinical Trials
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Cancer Type: Breast Cancer
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Cancer Type: Breast Cancer
Connect® Myeloid Disease Registry
Cancer Type: Cancer-Related Syndrome
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Cancer Type: Esophogeal Cancer
Connect® Myeloid Disease Registry
Cancer Type: Leukemia
Connect® Myeloid Disease Registry
Cancer Type: Myelodysplastic Syndromes (MDS)
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Cancer Type: Solid Tumor
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Cancer Type: Stomach/ Gastric Cancer
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Cancer Type: Unknown Primary
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Cancer Type: Unknown Primary
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
Cancer Type: Unknown Primary
Tanner Cancer Center
165 Clinic Avenue
Carrollton, GA 30117
770-836-9824 (p)
www.tanner.org
driving directions
Clinical Trials
WellStar Cobb Hospital
3950 Austell Road
Austell, GA 30106
770-732-4000 (p)
www.wellstar.org
driving directions
Clinical Trials
Active Clinical Trial Site Locations:
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please
contact us
.